my question with ecofibre's listing is market timing, given the volatility in the market presently, & not just the market in general but also FDA watchdog. the other thing is Lambert and the many other high profile investors wanting their cut, eventually, which asx yet to determine on timeline of escrowed shares, and not to mention high market cap
vs revenue.
I have questions, that's all I'm saying...glass half full v glass half empty?
Ecofibre Medical Cannabis float around Easter 2018, page-84
-
- There are more pages in this discussion • 83 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
